BiVictriX Therapeutics Statements
BV
Data from BiVictriX Therapeutics`s earning releases including common size income statement and balance sheet.
Common size analysis evaluates financial statements by expressing each line item as a percentage of a base amount for that period.
Key Information:
Report currency :
GBP - British pound
Last reporting period :
30 Jun, 2023
New report :
04 Mar, 2024
Reporting period :
Semi-annual
Earnings release date:
—
Expected release date:
—
BiVictriX Therapeutics Income Statement
B
M
GBP (except Earnings per share)
Financial
Revenue
Cost of sales
Gross profit
Research and development
Selling, general and administrative
Total operating expenses
Operating income
Interest expense
Other income
Income before tax
Provision for income taxes
Net income
Diluted earnings per share
Shares outstanding after dilution
—
—
100
—
0
—
—
0
1.051
0
0.339
0
1.39
-2.5 %
0
-1.39
2.5 %
0
—
0
—
0
-1.39
2.2 %
0
-0.219
0
-1.171
-1.2 %
0
-0.018
66.115
—
—
100
—
0
—
—
0
0.901
0
0.524
0
1.425
-8.1 %
0
-1.425
8.1 %
0
0.004
0
—
0
-1.421
8.3 %
0
-0.264
0
-1.157
13.7 %
0
-0.018
66.115
—
—
100
—
0
—
—
0
1.209
0
0.341
0
1.55
43.1 %
0
-1.55
-43.1 %
0
—
0
—
0
-1.55
25.5 %
0
-0.21
0
-1.34
29.1 %
0
-0.02
66.115
—
—
100
—
0
—
—
0
0.711
0
0.789
0
1.083
158.5 %
0
-1.083
-158.5 %
0
-0.609
0
—
0
-2.081
-361.4 %
0
-0.192
0
-1.889
-318.8 %
0
-0.034
54.818
—
—
100
—
0
—
—
0
—
0
0.002
0
0.419
29.7 %
0
-0.419
-29.7 %
0
-0.032
0
—
0
-0.451
-31.9 %
0
—
0
-0.451
-74.8 %
0
-0.02
22.914
—
—
100
—
0
—
—
0
—
0
0.002
0
0.323
93.4 %
0
-0.323
-93.4 %
0
-0.019
0
—
0
-0.342
-104.8 %
0
-0.084
0
-0.258
-54.5 %
0
-0.004
66.115
—
—
100
—
0
—
—
0
—
0
0.002
0
0.167
—
0
-0.167
—
0
—
0
—
0
-0.167
—
0
—
0
-0.167
—
0
-0.003
66.115